LBO Firms Exit Merck Generics Auction

Apax Partners and Bain Capital have pulled a joint bid for the generic drugs business of Merck KGaA, according to Reuters. The move leaves just a pair of strategics — Teva Pharmaceutical Industries Ltd. and Mylan Laboratories Inc.